search
Back to results

Tibial Nerve Stimulation for Faecal Incontinence

Primary Purpose

Fecal Incontinence

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Percutaneous posterior tibial nerve stimulation
Transcutaneous tibial nerve stimulation
Sham transcutaneous tibial nerve stimulation
Sponsored by
London North West Healthcare NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fecal Incontinence

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Over 18
  • Incontinence to solid or liquid faeces

Exclusion Criteria:

  • Previous congenital or acquired spinal injury, spinal tumour or spinal surgery
  • Neurological diseases, such as diabetic neuropathy, multiple sclerosis and Parkinson's disease
  • Peripheral vascular disease
  • Diabetes mellitus
  • Congenital anorectal malformations
  • Previous rectal surgery (rectopexy / resection) done < 12 months ago (24 months for cancer)
  • Present evidence of external full thickness rectal prolapse
  • Chronic bowel diseases such as inflammatory bowel disease
  • Chronic diarrhoea, uncontrolled by drugs or diet
  • Anatomical limitations that would prevent successful placement of an electrode
  • Previous use of transcutaneous electrical nerve stimulation Stoma in situ

Sites / Locations

  • St Mark's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Sham Comparator

Experimental

Experimental

Arm Label

1

2

3

Arm Description

Sham tibial nerve stimulation

Percutaneous tibial nerve stimulation

Transcutaneous tibial nerve stimulation

Outcomes

Primary Outcome Measures

The difference in the percentage of patients with a 20% reduction in episodes of faecal incontinence between the placebo and treatment groups.

Secondary Outcome Measures

The difference in the improvements in the St Mark's incontinence score, quality of life scales, and physiological parameters between the treatment and placebo groups.
The difference in the improvements in the urinary symptoms between placebo and treatment groups.

Full Information

First Posted
September 15, 2007
Last Updated
September 15, 2007
Sponsor
London North West Healthcare NHS Trust
Collaborators
Uroplasty, Inc
search

1. Study Identification

Unique Protocol Identification Number
NCT00530933
Brief Title
Tibial Nerve Stimulation for Faecal Incontinence
Official Title
Prospective Randomised Placebo Controlled Study Into Percutaneous and Transcutaneous Tibial Nerve Stimulation for Faecal Incontinence
Study Type
Interventional

2. Study Status

Record Verification Date
September 2007
Overall Recruitment Status
Unknown status
Study Start Date
September 2007 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
April 2009 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
London North West Healthcare NHS Trust
Collaborators
Uroplasty, Inc

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether tibial nerve stimulation is an effective treatment for faecal incontinence.
Detailed Description
Faecal incontinence is a common problem, affecting approximately 2% of the adult general population. Initial management involves dietary advice, anti-diarrhoeal medication, and behavioural therapy. In those who have not benefited from these conservative techniques sacral nerve stimulation is an established and effective treatment for faecal incontinence. This treatment involves using electrical pulses to stimulate the S3 nerve root - a nerve at the bottom of the back. These are the nerves which supply the lower end of the bowel, and the anal sphincter. It is believed that it is stimulation of the sensory fibres heading back towards the spinal cord at this level which is important for the therapeutic effect. To stimulate the sacral nerves however requires two operations under general anaesthetic, and surgical implantation of an expensive nerve stimulator. The tibial nerve also contains fibres that arise from the S3 part of the spinal cord. Electrical stimulation of the tibial nerve will therefore send sensory information back to the same region of the spinal cord as sacral nerve stimulation. The tibial nerve is much more easily accessible on the inside of the ankle, and this allows stimulation to be carried out as an outpatient and without the need for surgery. It can be performed either percutaneously (with a fine needle placed through the skin to sit next to the nerve), or transcutaneously. Tibial nerve stimulation has been successfully used for patients with urinary incontinence. There are small studies looking at tibial nerve stimulation for faecal incontinence which both show a benefit, but these studies are not controlled. We aim to determine in a randomised controlled trial whether either percutaneous or transcutaneous tibial nerve stimulation is an effective treatment for faecal incontinence.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fecal Incontinence

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
66 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Sham Comparator
Arm Description
Sham tibial nerve stimulation
Arm Title
2
Arm Type
Experimental
Arm Description
Percutaneous tibial nerve stimulation
Arm Title
3
Arm Type
Experimental
Arm Description
Transcutaneous tibial nerve stimulation
Intervention Type
Procedure
Intervention Name(s)
Percutaneous posterior tibial nerve stimulation
Intervention Description
Once weekly for 30 minutes
Intervention Type
Procedure
Intervention Name(s)
Transcutaneous tibial nerve stimulation
Intervention Description
30 minutes once weekly
Intervention Type
Procedure
Intervention Name(s)
Sham transcutaneous tibial nerve stimulation
Intervention Description
Once weekly for 30 minutes
Primary Outcome Measure Information:
Title
The difference in the percentage of patients with a 20% reduction in episodes of faecal incontinence between the placebo and treatment groups.
Time Frame
14 weeks
Secondary Outcome Measure Information:
Title
The difference in the improvements in the St Mark's incontinence score, quality of life scales, and physiological parameters between the treatment and placebo groups.
Time Frame
14 weeks
Title
The difference in the improvements in the urinary symptoms between placebo and treatment groups.
Time Frame
14 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Over 18 Incontinence to solid or liquid faeces Exclusion Criteria: Previous congenital or acquired spinal injury, spinal tumour or spinal surgery Neurological diseases, such as diabetic neuropathy, multiple sclerosis and Parkinson's disease Peripheral vascular disease Diabetes mellitus Congenital anorectal malformations Previous rectal surgery (rectopexy / resection) done < 12 months ago (24 months for cancer) Present evidence of external full thickness rectal prolapse Chronic bowel diseases such as inflammatory bowel disease Chronic diarrhoea, uncontrolled by drugs or diet Anatomical limitations that would prevent successful placement of an electrode Previous use of transcutaneous electrical nerve stimulation Stoma in situ
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
James Hollingshead, MRCS
Phone
020 8235 4081
Email
james.hollingshead@nhs.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James Hollingshead, MRCS
Organizational Affiliation
London North West Healthcare NHS Trust
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Carolynne Vaizey, MD FRCS FCS
Organizational Affiliation
London North West Healthcare NHS Trust
Official's Role
Study Director
Facility Information:
Facility Name
St Mark's Hospital
City
London
ZIP/Postal Code
W9 3EF
Country
United Kingdom
Individual Site Status
Recruiting

12. IPD Sharing Statement

Citations:
PubMed Identifier
23300071
Citation
George AT, Kalmar K, Sala S, Kopanakis K, Panarese A, Dudding TC, Hollingshead JR, Nicholls RJ, Vaizey CJ. Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence. Br J Surg. 2013 Feb;100(3):330-8. doi: 10.1002/bjs.9000.
Results Reference
derived

Learn more about this trial

Tibial Nerve Stimulation for Faecal Incontinence

We'll reach out to this number within 24 hrs